default author photo

Christof von Eiff

Pfizer Pharma

Linkstr. 10

Berlin, Berlin 10785

Germany

SCHOLARLY PAPERS

5

DOWNLOADS

416

TOTAL CITATIONS

1

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Case Fatality Risk and Attributable Costs in Patients Treated for Community-Acquired Pneumonia in Germany: A Population-Based Healthcare Claims Data Cohort Study

Number of pages: 51 Posted: 13 Jun 2022
Ernestine Mahar, Ralf Sprenger, Joanna Diesing, Nils Kossack, Dennis Häckl and Christof von Eiff
Pfizer Pharma GmbH, Pfizer Pharma GmbH, Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Scientific Institute for Health Economics and Health System Research (WIG2 GmbH) and Pfizer Pharma
Downloads 113 (626,371)
Citation 1

Abstract:

Loading...

CAP, Community acquired pneumonia, Medical claims study, pneumonia, pneumococcus, Streptococcus pneumoniae, attributable fatality, attributable costs, medical costs, social costs, Case fatality, longitudinal study, CFR

2.

Pneumococcal Vaccination Rates in Immunocompromised Patients in Germany: A Retrospective Cohort Study to Assess Sequential Vaccination Rates and Changes Over Time

Number of pages: 33 Posted: 05 Oct 2021
Ralf Sprenger, Dennis Häckl, Nils Kossack, Julia Schiffner-Rohe, Jessica Wohlleben and Christof von Eiff
Pfizer Pharma GmbH, Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Pfizer Deutschland GmbH, Pfizer Deutschland GmbH and Pfizer Pharma
Downloads 107 (654,668)

Abstract:

Loading...

pneumococcal vaccination rates, immunocompromised patients, sequential pneumococcal vaccination

3.

Knowledge, Attitudes and Practices on Tick-Borne Encephalitis Vaccination and Prevention in Germany: Results of a Nationwide Household Survey

Number of pages: 16 Posted: 01 Aug 2025
Claudius Malerczyk, Lara Schröder, Andreas Pilz and Christof von Eiff
Pfizer Pharma GmbH, Pfizer Pharma GmbH, Pfizer Biopharma Group and Pfizer Pharma
Downloads 77 (837,727)

Abstract:

Loading...

Tick-borne encephalitis, Vaccination, Household survey, Knowledge, attitudes and practices (KAP), Germany

4.

Mathematical Modeling of Pneumococcal Transmission Dynamics in Response to PCV13 Infant Vaccination in Germany Predicts Increasing IPD Burden Due to Serotypes Included in Next-Generation PCVs

Number of pages: 24 Posted: 22 Feb 2022 Last Revised: 13 Jan 2023
Matthias Horn, Christian Theilacker, Ralf Sprenger, Christof von Eiff, Ernestine Mahar, Julia Schiffner-Rohe, Mathias W. Pletz, Mark van der Linden and Markus Scholz
University of Leipzig - Institute for Medical Informatics, Statistics and Epidemiology (IMISE), Pfizer Pharma GmbH, Pfizer Pharma GmbH, Pfizer Pharma, Pfizer Pharma GmbH, Pfizer Deutschland GmbH, Friedrich-Schiller-Universität Jena, RWTH Aachen University - RWTH University Hospital Aachen and University of Leipzig
Downloads 75 (852,604)

Abstract:

Loading...

Pneumococcal, conjugate vaccines, Pneumoccocal serotype dynamic, mathematical modelling

5.

Long-term Sequelae After Tick-Borne Encephalitis in Germany: A Nationwide Claims-Based Matched Cohort Study

Number of pages: 28 Posted: 16 Apr 2026
Guy Levy, Daniel Gensorowsky, Jana Diekmannshemke, Julia Schiffner-Rohe, Uta Meyding-Lamadé, Florian Reis, Christof von Eiff, Julian Witte and Claudius Malerczyk
Pfizer Pharma GmbH, Vandage GmbH, Vandage GmbH, Pfizer Deutschland GmbH, affiliation not provided to SSRN, Pfizer Pharma GmbH, Pfizer Pharma, Vandage GmbH and Pfizer Pharma GmbH
Downloads 44 (1,249,711)

Abstract:

Loading...

Tick-Borne Encephalitis (TBE), Epidemiology, Sequelae, Real-World Data, Germany